Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean?
Aliment Pharmacol Ther
.
2022 May;55(9):1218-1219.
doi: 10.1111/apt.16909.
Author
Eamonn M M Quigley
1
Affiliation
1
Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital and Weill Cornell Medical College, Houston, Texas, USA.
PMID:
35429038
DOI:
10.1111/apt.16909
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Attitude to Health
Humans
Irritable Bowel Syndrome*
Surveys and Questionnaires